3/16/25, 3:52 PM NR 565 Midterm 2023
NR 565 Midterm 2023
NURS 565 MIDTERM 2023 TEST BANK NEWEST ACTUAL EXAM
COMPLETEQUESTIONS AND CORRECT DETAILED ANSWERS
(VERIFIED ANSWERS) |ALREADY GRADED A+||BRAND NEW
VERSION 2025
Terms in this set (110)
When prescribing B. Decreased blood flow to liver
Medications, we must
understand that the liver
function declines with age
d/t what?
A. Enlarged Liver
B. Decreased blood flow to liver
C. Increased activity of
the hepatic enzymes
An 82 yo male visits the clinic B. Sometimes as you get older, absorption may be slower
complaining that his pain resulting in a delayed response
meds "take forever" to work C. As we get older, the gastric acid decreases and may delay
absorption
after he takes his pill. What
are possible reasons you can
explain to him as to why this
may be happening.
A. Perhaps we need to increase
your dose
B. Sometimes as you get older,
absorption may be slower
resulting in a delayed
response
C. As we get older, the
gastric acid decreases
and may delay absorption
1/1
7
,3/16/25, 3:52 PM NR 565 Midterm 2023
RA Characteristics weeks-
months
Onset women>
Affected men
population common hands, feet, & wrists
Location >60 min in
Joint stiffness AM local
duration SxS & sys.
2/1
7
, 3/16/25, 3:52 PM NR 565 Midterm 2023
OA Characteristics years
men & Women
Onset equally Hands &
Affected weight baring joints
population <30min
Location in AM
Joint stiffness typically
duration SxS local
What might you expect to find Mild leukocytes
in the synovial fluid of a pt
with OA
What might you expect to find Cloudy with leukocytes
in the synovial fluid of a pt
with RA
Sxs relief (pain, stiffness,
inflammation, maintaining
Goals of Tx for RA
joint fxn and ROM
minimize systemic
involvement
delay progression
Typical pharm Txs for RA NSAIDs, systemic steroids, antimalarials, antimetabolites, and biologics
Baseline assessment data Liver, PG, serum creatinine, CBC with diff, sxs of infxn (TB &
before starting DMARD hepatits), Hx & physical, renal status, & malignancies
Significant baseline data for CXR, pulmonary and neuro status
Sulfasalazine
Significant baseline data for CXR, BP & pulmonary status
Leflunomide
Significant baseline data for CXR, Pulmonary and GI status
Mehtotrexate
Significant baseline data for Ophthalmologic & cardiac exam (ECG if indicated)
hydroxychloroquine
Conventional DMARDs- Methotrexate, hydroxychloroquine, sulfsalazine
examples
adalimumab, etanercept, golimumab
Biologic DMARDS- examples
"-mab"s
MOA of methotrexate folic acid antagonist ->inhibits lymphocyte proliferation
3 months of diagnosis
Within how many months of
RA diagnosis should
delay joint degeneration
Methotrexate be started and
why?
3/1
7
NR 565 Midterm 2023
NURS 565 MIDTERM 2023 TEST BANK NEWEST ACTUAL EXAM
COMPLETEQUESTIONS AND CORRECT DETAILED ANSWERS
(VERIFIED ANSWERS) |ALREADY GRADED A+||BRAND NEW
VERSION 2025
Terms in this set (110)
When prescribing B. Decreased blood flow to liver
Medications, we must
understand that the liver
function declines with age
d/t what?
A. Enlarged Liver
B. Decreased blood flow to liver
C. Increased activity of
the hepatic enzymes
An 82 yo male visits the clinic B. Sometimes as you get older, absorption may be slower
complaining that his pain resulting in a delayed response
meds "take forever" to work C. As we get older, the gastric acid decreases and may delay
absorption
after he takes his pill. What
are possible reasons you can
explain to him as to why this
may be happening.
A. Perhaps we need to increase
your dose
B. Sometimes as you get older,
absorption may be slower
resulting in a delayed
response
C. As we get older, the
gastric acid decreases
and may delay absorption
1/1
7
,3/16/25, 3:52 PM NR 565 Midterm 2023
RA Characteristics weeks-
months
Onset women>
Affected men
population common hands, feet, & wrists
Location >60 min in
Joint stiffness AM local
duration SxS & sys.
2/1
7
, 3/16/25, 3:52 PM NR 565 Midterm 2023
OA Characteristics years
men & Women
Onset equally Hands &
Affected weight baring joints
population <30min
Location in AM
Joint stiffness typically
duration SxS local
What might you expect to find Mild leukocytes
in the synovial fluid of a pt
with OA
What might you expect to find Cloudy with leukocytes
in the synovial fluid of a pt
with RA
Sxs relief (pain, stiffness,
inflammation, maintaining
Goals of Tx for RA
joint fxn and ROM
minimize systemic
involvement
delay progression
Typical pharm Txs for RA NSAIDs, systemic steroids, antimalarials, antimetabolites, and biologics
Baseline assessment data Liver, PG, serum creatinine, CBC with diff, sxs of infxn (TB &
before starting DMARD hepatits), Hx & physical, renal status, & malignancies
Significant baseline data for CXR, pulmonary and neuro status
Sulfasalazine
Significant baseline data for CXR, BP & pulmonary status
Leflunomide
Significant baseline data for CXR, Pulmonary and GI status
Mehtotrexate
Significant baseline data for Ophthalmologic & cardiac exam (ECG if indicated)
hydroxychloroquine
Conventional DMARDs- Methotrexate, hydroxychloroquine, sulfsalazine
examples
adalimumab, etanercept, golimumab
Biologic DMARDS- examples
"-mab"s
MOA of methotrexate folic acid antagonist ->inhibits lymphocyte proliferation
3 months of diagnosis
Within how many months of
RA diagnosis should
delay joint degeneration
Methotrexate be started and
why?
3/1
7
